Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.
The platform, called RapI.D., is the first iteration of the microfluidic-based DNA testing platform ZyGem took on when it acquired MicroLab Diagnostics earlier this year.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.